Aitsa Jimenez Velez
Hematology & Oncology · San Juan, PRNPI 1891731675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,323, more than ten times the $20 reported in 2019. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 177 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$471
- AstraZeneca$467
- E.r. Squibb & Sons, L.L.C.$389
- PBG Puerto Rico LLC$308
- Amgen$285
- AbbVie$262
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,70395%
- Education$1845%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 21 | $471 |
| AstraZeneca | 19 | $467 |
| E.r. Squibb & Sons, L.L.C. | 21 | $389 |
| PBG Puerto Rico LLC | 15 | $308 |
| Amgen | 13 | $285 |
| AbbVie | 12 | $262 |
| Merck | 14 | $258 |
| Eli Lilly Export S.A. Puerto Rico Branch | 10 | $215 |
| Novartis | 9 | $213 |
| Sanofi | 6 | $144 |
| Genentech USA, Inc. | 7 | $137 |
| Pfizer | 2 | $120 |
| Puma Biotechnology, Inc. | 5 | $110 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| Caris MPI, Inc. | 4 | $94 |
| Incyte Corporation | 3 | $68 |
| Sobi, Inc | 2 | $43 |
| Tempus AI, Inc | 2 | $35 |
| Exelixis Inc. | 1 | $25 |
| Bayer | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| Gilead | 1 | $23 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Morphosys, US Inc. | 1 | $21 |
| Seagen Inc. | 1 | $21 |
| Pharmaand GmbH | 1 | $12 |
How this compares
$3,887 in reported general payments places this provider in the 30th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $571 |
| Anastrozole | 11 | $186 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.